BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11140696)

  • 21. Combined use of expression and CGH arrays pinpoints novel candidate genes in Ewing sarcoma family of tumors.
    Savola S; Klami A; Tripathi A; Niini T; Serra M; Picci P; Kaski S; Zambelli D; Scotlandi K; Knuutila S
    BMC Cancer; 2009 Jan; 9():17. PubMed ID: 19144156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The EWS/FLI1 oncogenic transcription factor deregulates GLI1.
    Zwerner JP; Joo J; Warner KL; Christensen L; Hu-Lieskovan S; Triche TJ; May WA
    Oncogene; 2008 May; 27(23):3282-91. PubMed ID: 18084326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differentiating Ewing's sarcoma from other round blue cell tumors using a RT-PCR translocation panel on formalin-fixed paraffin-embedded tissues.
    Lewis TB; Coffin CM; Bernard PS
    Mod Pathol; 2007 Mar; 20(3):397-404. PubMed ID: 17334332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EWS-erg and EWS-Fli1 fusion transcripts in Ewing's sarcoma and primitive neuroectodermal tumors with variant translocations.
    Giovannini M; Biegel JA; Serra M; Wang JY; Wei YH; Nycum L; Emanuel BS; Evans GA
    J Clin Invest; 1994 Aug; 94(2):489-96. PubMed ID: 8040301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of an inhibitor of the EWS-FLI1 oncogenic transcription factor by high-throughput screening.
    Grohar PJ; Woldemichael GM; Griffin LB; Mendoza A; Chen QR; Yeung C; Currier DG; Davis S; Khanna C; Khan J; McMahon JB; Helman LJ
    J Natl Cancer Inst; 2011 Jun; 103(12):962-78. PubMed ID: 21653923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients?
    Zoubek A; Dockhorn-Dworniczak B; Delattre O; Christiansen H; Niggli F; Gatterer-Menz I; Smith TL; Jürgens H; Gadner H; Kovar H
    J Clin Oncol; 1996 Apr; 14(4):1245-51. PubMed ID: 8648380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The evaluation of CD99 immunoreactivity and EWS/FLI1 translocation by fluorescence in situ hybridization in central PNETs and Ewing's sarcoma family of tumors.
    Vural C; Uluoğlu O; Akyürek N; Oğuz A; Karadeniz C
    Pathol Oncol Res; 2011 Sep; 17(3):619-25. PubMed ID: 21267687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the Children's Oncology Group.
    van Doorninck JA; Ji L; Schaub B; Shimada H; Wing MR; Krailo MD; Lessnick SL; Marina N; Triche TJ; Sposto R; Womer RB; Lawlor ER
    J Clin Oncol; 2010 Apr; 28(12):1989-94. PubMed ID: 20308669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of the transcriptional function of p53 by EWS-Fli1 chimeric protein in Ewing Family Tumors.
    Li Y; Tanaka K; Fan X; Nakatani F; Li X; Nakamura T; Takasaki M; Yamamoto S; Iwamoto Y
    Cancer Lett; 2010 Aug; 294(1):57-65. PubMed ID: 20153576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ewing's sarcoma oncoprotein EWS-FLI1: the perfect target without a therapeutic agent.
    Uren A; Toretsky JA
    Future Oncol; 2005 Aug; 1(4):521-8. PubMed ID: 16556028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Junction region of EWS-FLI1 fusion protein has a dominant negative effect in Ewing's sarcoma in vitro.
    Jully B; Vijayalakshmi R; Gopal G; Sabitha K; Rajkumar T
    BMC Cancer; 2012 Nov; 12():513. PubMed ID: 23145994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmaceutical Interference of the EWS-FLI1-driven Transcriptome By Cotargeting H3K27ac and RNA Polymerase Activity in Ewing Sarcoma.
    Heisey DAR; Jacob S; Lochmann TL; Kurupi R; Ghotra MS; Calbert ML; Shende M; Maves YK; Koblinski JE; Dozmorov MG; Boikos SA; Benes CH; Faber AC
    Mol Cancer Ther; 2021 Oct; 20(10):1868-1879. PubMed ID: 34315769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular detection of EWS-FLI1 chimeric transcripts in Ewing family tumors by nested reverse transcription-polymerase chain reaction: application to archival paraffin-embedded tumor tissues.
    Hisaoka M; Tsuji S; Morimitsu Y; Hashimoto H; Shimajiri S; Komiya S; Ushijima M
    APMIS; 1999 Jun; 107(6):577-84. PubMed ID: 10379685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Olfactory neuroblastoma is a peripheral primitive neuroectodermal tumor related to Ewing sarcoma.
    Sorensen PH; Wu JK; Berean KW; Lim JF; Donn W; Frierson HF; Reynolds CP; López-Terrada D; Triche TJ
    Proc Natl Acad Sci U S A; 1996 Feb; 93(3):1038-43. PubMed ID: 8577710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EWS-FLI1 fusion protein up-regulates critical genes in neural crest development and is responsible for the observed phenotype of Ewing's family of tumors.
    Hu-Lieskovan S; Zhang J; Wu L; Shimada H; Schofield DE; Triche TJ
    Cancer Res; 2005 Jun; 65(11):4633-44. PubMed ID: 15930281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cloning of the entire FLI1 gene, disrupted by the Ewing's sarcoma translocation breakpoint on 11q24, in a yeast artificial chromosome.
    Selleri L; Giovannini M; Romo A; Zucman J; Delattre O; Thomas G; Evans GA
    Cytogenet Cell Genet; 1994; 67(2):129-36. PubMed ID: 8039423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relation of neurological marker expression and EWS gene fusion types in MIC2/CD99-positive tumors of the Ewing family.
    Amann G; Zoubek A; Salzer-Kuntschik M; Windhager R; Kovar H
    Hum Pathol; 1999 Sep; 30(9):1058-64. PubMed ID: 10492040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumor.
    Franzetti GA; Laud-Duval K; Bellanger D; Stern MH; Sastre-Garau X; Delattre O
    Oncogene; 2013 Aug; 32(33):3915-21. PubMed ID: 22986530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of the (11;22)(q24;q12) translocation of Ewing's sarcoma and peripheral neuroectodermal tumor by reverse transcription polymerase chain reaction.
    Downing JR; Head DR; Parham DM; Douglass EC; Hulshof MG; Link MP; Motroni TA; Grier HE; Curcio-Brint AM; Shapiro DN
    Am J Pathol; 1993 Nov; 143(5):1294-300. PubMed ID: 8238248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Translocation (10;11;22)(p14;q24;q12) characterized by fluorescence in situ hybridization in a case of Ewing's tumor.
    Noguera R; Pellín A; Navarro S; Carda C; Llombart-Bosch A
    Diagn Mol Pathol; 2001 Mar; 10(1):2-8. PubMed ID: 11277391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.